Our reports provide an independent, expert view supported by robust and innovative data interrogation and analysis.

Refine Sector
Sub-Category
Clear
Publish Date
Clear
Region
Clear
Clear All
Sort by:
Hepatitis C Therapeutics in Asia-Pacific Markets to 2023 – Presence of Outstanding Direct-Acting Antivirals and Late-Stage Pipeline to Transform the Clinical and Commercial Landscape

Published: Aug-2017

Hepatitis C is a blood-borne liver disease caused by the hepatitis C virus (HCV), which can lead to acute and chronic.....

$4995
More Info
Global Ophthalmology Drugs Market to 2023- Angiogenesis Inhibitors in wAMD Set to Retain High Market Share, While Expansive Pipeline for Glaucoma Leads the Research Landscape

Published: Aug-2017

Ophthalmology is a broad therapy area that consists of almost 100 disorders associated with the eyes and visual system,.....

$4995
More Info
Global Dermatology Drugs Market to 2023 – Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis

Published: Jul-2017

Dermatology is a highly diverse therapy area that deals with diseases of the skin, hair and nails. Over 3,000 types of.....

$4995
More Info
Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2023 – Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

Published: Jul-2017

Colorectal Cancer (CRC) is the most common cancer and the leading cause of cancer-related mortality globally. There were.....

$4995
More Info
Asthma Therapeutics in Asia-Pacific Markets to 2023 – High Prevalence and Highly Priced Existing & Upcoming Biologics will Drive the Market

Published: Jun-2017

Asthma is a common chronic inflammatory disease of the airways, characterized by recurrent attacks of breathlessness and.....

$4995
More Info
Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse

Published: Jun-2017

The pain therapeutics market covers the drugs used for the relief of acute and chronic pain. This market has long been.....

$4995
More Info
Global Oncology Market to 2023 – Robust Growth Driven by Rising Prevalence and Increased Uptake of Immune Checkpoint Inhibitors

Published: Jun-2017

In 2012, there were 32.6 million people living with any type of cancer within five years of diagnosis. These are generally.....

$4995
More Info
Global Immunology Drugs Market to 2022 –Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth

Published: May-2017

Immunology is a therapy area characterized by disorders of the immune system, specifically an aberrant autoimmune response.....

$4995
More Info
Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 – Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

Published: Apr-2017

Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects.....

$4995
More Info
Breast Cancer Therapeutics in Southeast Asia Markets to 2022 – Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market

Published: Apr-2017

Breast cancer is a malignant neoplasm that begins in the breast tissue. Most breast cancers are invasive cancers that.....

$4995
More Info
Sort by: